Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-052778

Director bought 111,203 shares at an average $1.28 ($142,512)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-04 Purchase : show line 1 in the form +95,541 $1.29 $123,248 457,455 D
2022-10-05 Purchase : show line 2 in the form +15,662 $1.23 $19,264 473,117 D
Open-market purchases · 111,203 sh · avg $1.28 · $142,512
Loading xslF345X03/doc4.xml…